Intestinal Research  
Quality indicators in inflammatory bowel disease
Sameer K. Berry, Gil Y. Melmed
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Correspondence to: Gil Y Melmed, Department of Medicine, Cedars-Sinai Medical Center, Inflammatory Bowel Disease Center, 8730 Alden Drive, Second Floor East, Los Angeles, CA 90048, USA. Tel: +1-310-423-4100, Fax: +1-310-423-0146, E-mail: Gil.Melmed@cshs.org
Received: May 11, 2017; Revised: June 6, 2017; Accepted: June 7, 2017; Published online: August 31, 2017.
© Korean Association for the Study of Intestinal Diseases. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a chronic, debilitating, and expensive condition affecting millions of people globally. There is significant variation in the quality of care for patients with IBD across North America, Europe, and Asia; this variation suggests poor quality of care due to overuse, underuse, or misuse of health services and disparity of outcomes. Several initiatives have been developed to reduce variation in care delivery and improve processes of care, patient outcomes, and reduced healthcare costs. These initiatives include the development of quality indicator sets to standardize care across organizations, and learning health systems to enable data sharing between doctors and patients, and sharing of best practices among providers. These programs have been variably successful in improving patient outcomes and reducing healthcare utilization. Further studies are needed to demonstrate the long-term impact and applicability of these efforts in different geographic areas around the world, as regional variations in patient populations, societal preferences, and costs should inform local quality improvement efforts.
Keywords: Quality indicator, health care; Inflammatory bowel disease; Crohn disease; Colitis, ulcerative


This Article

e-submission

Archives

Official Journal of

Indexed/Covered by